These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
825 related articles for article (PubMed ID: 28687971)
21. Germline mutation prevalence in individuals with pancreatic cancer and a history of previous malignancy. Dudley B; Karloski E; Monzon FA; Singhi AD; Lincoln SE; Bahary N; Brand RE Cancer; 2018 Apr; 124(8):1691-1700. PubMed ID: 29360161 [TBL] [Abstract][Full Text] [Related]
22. Germline Genetic Features of Young Individuals With Colorectal Cancer. Stoffel EM; Koeppe E; Everett J; Ulintz P; Kiel M; Osborne J; Williams L; Hanson K; Gruber SB; Rozek LS Gastroenterology; 2018 Mar; 154(4):897-905.e1. PubMed ID: 29146522 [TBL] [Abstract][Full Text] [Related]
23. Germline BRCA Mutations in a Large Clinic-Based Cohort of Patients With Pancreatic Adenocarcinoma. Holter S; Borgida A; Dodd A; Grant R; Semotiuk K; Hedley D; Dhani N; Narod S; Akbari M; Moore M; Gallinger S J Clin Oncol; 2015 Oct; 33(28):3124-9. PubMed ID: 25940717 [TBL] [Abstract][Full Text] [Related]
24. Pathologic findings in breast, fallopian tube, and ovary specimens in non-BRCA hereditary breast and/or ovarian cancer syndromes: a study of 18 patients with deleterious germline mutations in RAD51C, BARD1, BRIP1, PALB2, MUTYH, or CHEK2. Schoolmeester JK; Moyer AM; Goodenberger ML; Keeney GL; Carter JM; Bakkum-Gamez JN Hum Pathol; 2017 Dec; 70():14-26. PubMed ID: 28709830 [TBL] [Abstract][Full Text] [Related]
26. Multiple-gene panel analysis in a case series of 255 women with hereditary breast and ovarian cancer. Tedaldi G; Tebaldi M; Zampiga V; Danesi R; Arcangeli V; Ravegnani M; Cangini I; Pirini F; Petracci E; Rocca A; Falcini F; Amadori D; Calistri D Oncotarget; 2017 Jul; 8(29):47064-47075. PubMed ID: 28423363 [TBL] [Abstract][Full Text] [Related]
27. Hereditary truncating mutations of DNA repair and other genes in BRCA1/BRCA2/PALB2-negatively tested breast cancer patients. Lhota F; Zemankova P; Kleiblova P; Soukupova J; Vocka M; Stranecky V; Janatova M; Hartmannova H; Hodanova K; Kmoch S; Kleibl Z Clin Genet; 2016 Oct; 90(4):324-33. PubMed ID: 26822949 [TBL] [Abstract][Full Text] [Related]
28. Burden of hereditary cancer susceptibility in unselected patients with pancreatic ductal adenocarcinoma referred for germline screening. Cremin C; Lee MK; Hong Q; Hoeschen C; Mackenzie A; Dixon K; McCullum M; Nuk J; Kalloger S; Karasinska J; Scudamore C; Kim PTW; Donnellan F; Lam ECS; Lim HJ; Neben CL; Stedden W; Zhou AY; Schaeffer DF; Sun S; Renouf DJ; Schrader KA Cancer Med; 2020 Jun; 9(11):4004-4013. PubMed ID: 32255556 [TBL] [Abstract][Full Text] [Related]
29. Germline mutations in homologous recombination repair genes among Chinese pancreatic ductal adenocarcinoma patients detected using next-generation sequencing. Jiang H; Huang F; Chen X; Zhang L; Shen M; Pan B; Wang B; Guo W Mol Genet Genomic Med; 2023 Jul; 11(7):e2170. PubMed ID: 36978154 [TBL] [Abstract][Full Text] [Related]
30. Next-generation universal hereditary cancer screening: implementation of an automated hereditary cancer screening program for patients with advanced cancer undergoing tumor sequencing in a large HMO. Hoffman TL; Kershberg H; Goff J; Holmquist KJ; Haque R; Alvarado M Fam Cancer; 2023 Apr; 22(2):225-235. PubMed ID: 36261688 [TBL] [Abstract][Full Text] [Related]
31. Evaluation of Fanconi Anemia genes in familial breast cancer predisposition. Seal S; Barfoot R; Jayatilake H; Smith P; Renwick A; Bascombe L; McGuffog L; Evans DG; Eccles D; Easton DF; Stratton MR; Rahman N; Cancer Res; 2003 Dec; 63(24):8596-9. PubMed ID: 14695169 [TBL] [Abstract][Full Text] [Related]
32. Inherited DNA repair gene mutations detected by tumor next generation sequencing in urinary tract cancers. Gupta S; Greenberg S; Grimmett J; Gaston D; Agarwal N; Lowrance W; Schiffman J; Kohlmann W Fam Cancer; 2017 Oct; 16(4):545-550. PubMed ID: 28315974 [TBL] [Abstract][Full Text] [Related]
33. Comprehensive detection of germline variants by MSK-IMPACT, a clinical diagnostic platform for solid tumor molecular oncology and concurrent cancer predisposition testing. Cheng DT; Prasad M; Chekaluk Y; Benayed R; Sadowska J; Zehir A; Syed A; Wang YE; Somar J; Li Y; Yelskaya Z; Wong D; Robson ME; Offit K; Berger MF; Nafa K; Ladanyi M; Zhang L BMC Med Genomics; 2017 May; 10(1):33. PubMed ID: 28526081 [TBL] [Abstract][Full Text] [Related]
34. Double germline mutations in APC and BRCA2 in an individual with a pancreatic tumor. Goehringer C; Sutter C; Kloor M; Gebert J; Slater EP; Keller M; Treiber I; Ganschow P; Kadmon M; Moog U Fam Cancer; 2017 Apr; 16(2):303-309. PubMed ID: 27838800 [TBL] [Abstract][Full Text] [Related]
35. Prevalence and spectrum of pathogenic germline variants in intestinal and pancreatobiliary type of ampullary cancer. Kumari N; Singh RK; Mishra SK; L R; Mohindra S; Krishnani N Pathol Res Pract; 2021 Jan; 217():153309. PubMed ID: 33341547 [TBL] [Abstract][Full Text] [Related]
36. Association Between Inherited Germline Mutations in Cancer Predisposition Genes and Risk of Pancreatic Cancer. Hu C; Hart SN; Polley EC; Gnanaolivu R; Shimelis H; Lee KY; Lilyquist J; Na J; Moore R; Antwi SO; Bamlet WR; Chaffee KG; DiCarlo J; Wu Z; Samara R; Kasi PM; McWilliams RR; Petersen GM; Couch FJ JAMA; 2018 Jun; 319(23):2401-2409. PubMed ID: 29922827 [TBL] [Abstract][Full Text] [Related]